CONNECTA THERAPEUTICS
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
CONNECTA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Neuroscience
Founded:
2019-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.connectatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+34 649 82 40 40
Email Addresses:
[email protected]
Total Funding:
1.7 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Inveready
Inveready investment in Seed Round - Connecta Therapeutics
Centre for the Development of Industrial Technology (CDTI)
Centre for the Development of Industrial Technology (CDTI) investment in Seed Round - Connecta Therapeutics
Official Site Inspections
http://www.connectatherapeutics.com Semrush global rank: 6.16 M Semrush visits lastest month: 1.31 K
- Host name: 217-160-0-224.elastic-ssl.ui-r.com
- IP address: 217.160.0.224
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Connecta Therapeutics"
ABOUT US – CONNECTA Therapeutics
The company was founded in July 2019 as a spin-off of Prous Institute Biomedical Research, a private research organization based in Barcelona. In September 2020, we completed a seed …See details»
PIPELINE – CONNECTA Therapeutics
We are an innovation-oriented, R&D-intensive organization, committed to the development of innovative treatments for patients. R&D APPROACH CONNECTA follows a network pharmacology-based approach by evaluating …See details»
Connecta Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +34 649 82 40 40 Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved …See details»
Connecta Therapeutics Company Profile | Management and
Www.connectatherapeutics.com Connecta Therapeutics Profile and History CONNECTA is a clinical stage biotechnology company committed to developing new treatments for central …See details»
CONNECTA Therapeutics - LinkedIn
CONNECTA Therapeutics S.L. is a biotechnology company that develops new treatments for CNS unmet medical needs. The company is initially focus on the clinical development of a new “first-in ...See details»
Connecta Therapeutics - Parc Científic de Barcelona
Connecta Therapeutics Biotechnology - Therapeutics and Diagnostics . CONNECTA Therapeutics is a clinical stage biotechnology company committed to developing new …See details»
CONNECTA THERAPEUTICS | AseBio
CONNECTA Therapeutics is a clinical-stage biotechnology company committed to developing new treatments for Central Nervous System (CNS) disorders that lack therapeutic options, …See details»
CONNECTA THERAPEUTICS, A PROUS INSTITUTE SPIN-OFF, …
Jun 6, 2023 This Phase I clinical trial will assess the safety and tolerability of CTH120, which acts as a neuroplasticity modulator. CTH120 has shown very promising results in preclinical …See details»
Connecta Therapeutics - VentureRadar
Website: https://connectatherapeutics.com/ The company is currently focused on the clinical development of a new first-in-class molecule, CTH120, for the treatment of ...See details»
CONNECTA THERAPEUTICS RAISES €1.7 M TO DEVELOP NEW …
Sep 26, 2020 Prous Institute for Biomedical Research is a private research organization based in Barcelona that was created as a spin-off from Prous Science, a leading provider of scientific …See details»
Connecta Therapeutics - Overview, News & Similar companies
Feb 11, 2024 View Connecta Therapeutics (www.connectatherapeutics.com) location in Catalonia, Spain , revenue, industry and description. Find related and similar companies as …See details»
CONNECTA Therapeutics - PitchBook
Www.connectatherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. Parc Científic de Barcelona; CL/Baldiri Reixac, …See details»
Connecta Therapeutics Company Information - Funding, Investors, …
Https://connectatherapeutics.com. Developer of new treatments for central nervous system (CNS) disorders. GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY …See details»
CONTACT – CONNECTA Therapeutics
You can exercise your rights in [email protected]. Submit. Head Office. Parc Científic de Barcelona. Baldiri Reixac, 10-12. 08028 Barcelona. Spain. CONTACT; LEGAL …See details»
Connecta Therapeutics - Company Profile - Tracxn
Aug 30, 2024 Connecta Therapeutics - Developer of drugs for treating neurological disorders. Raised a total funding of $4.89M over 2 rounds from 6 investors. Founded by Jordi Fabrega …See details»
Connecta Therapeutics | EU-Startups
Articles about Connecta Therapeutics: February 16, 2024 Weekly funding round-up! All of the European startup funding rounds we tracked this week (February 12 – February 16)See details»
Connecta Therapeutics receives funding to expand therapeutic ...
Feb 3, 2022 Connecta Therapeutics, a biotechnology company that specialises in the discovery and development of new treatments for unmet central nervous system (CNS) needs, has been …See details»
CONNECTA THERAPEUTICS SL at Barcelona & Catalonia Startup Hub
CONNECTA therapeutics is a clinical stage biotechnology company committed to developing new therapies for CNS disorders without current treatment options. Our leading program CTH120 …See details»
NEWS - CONNECTA Therapeutics
Jul 20, 2023 CONNECTA Therapeutics, CRG, Hospital del Mar Research Institute and I3PT receive €2.7 million from the Spanish Ministry of Science and Innovation to begin Phase IIa …See details»